bifidobacterium breve + lactobacillus rhamnosus Capsules

Country of origin
European Union
GMP approvals
Recommended use
Digestive health
Product description
For the well-being of the intestine and the genitourinary tract. Contains no gluten or lactose sources. Find directions in case of: - iatrogenic diarrhea (from antibiotics and / or other drugs that cause diarrhea); - traveler's diarrhea (including prophylactically); - adjuvant treatment of specific therapies in cystitis and vulvo-vaginitis and as a prevention of symptomatic relapses associated with intestinal dysmicrobisms; - irritable bowel syndrome.
Manufacturer #610
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in EU, Middle East, LATAM, CIS, and Asia for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. Main therapeutic areas include CNS, antibiotics, and the cardiovascular system.

Manufacturer usually replies in 5 days